Begin main content

Drug Reimbursement Recommendation - Xultophy

Published on: October 28, 2019
Result type: News

Today, CADTH has issued final recommendations for:

insulin degludec + liraglutide (Xultophy)

Indications: Diabetes mellitus, Type 2
Recommendation: Reimburse with clinical criteria and/or conditions

For more information